US Stock MarketDetailed Quotes

MRKR Marker Therapeutics

Watchlist
  • 3.8000
  • +0.0700+1.88%
Close Dec 20 16:00 ET
33.91MMarket Cap-3.49P/E (TTM)

Marker Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Marker Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.000M--
--2024/Q4-- / 1.000M--
--2024/Q31.926M / 1.000M--
--2024/Q21.169M / 0.000--
--2024/Q11.244M / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.000M--
--2024/Q4-- / 1.000M--
--2024/Q31.926M / 1.000M--
--2024/Q21.169M / 0.000--
--2024/Q11.244M / 0.000--

Unlock Free Earnings Estimates

Marker Therapeutics Earnings Reports

  • Marker Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 15 06:03

  • Marker Therapeutics | 8-K: Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

    Nov 15 05:52

  • Marker Therapeutics | 8-K: Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates

    Aug 15 04:51

  • Marker Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 15 04:44

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 22, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data